Novel class of pain drugs based on antagonism of NGF - PubMed (original) (raw)
Review
Novel class of pain drugs based on antagonism of NGF
Franz F Hefti et al. Trends Pharmacol Sci. 2006 Feb.
Abstract
Nerve growth factor (NGF) was identified originally as a survival factor for sensory and sympathetic neurons in the developing nervous system. In adults, NGF is not required for survival but it has a crucial role in the generation of pain and hyperalgesia in several acute and chronic pain states. The expression of NGF is high in injured and inflamed tissues, and activation of the NGF receptor tyrosine kinase trkA on nociceptive neurons triggers and potentiates pain signalling by multiple mechanisms. Inhibition of NGF function and signalling blocks pain sensation as effectively as cyclooxygenase inhibitors and opiates in rodent models of pain. Several pharmaceutical companies have active drug-discovery and development programs that are based on a variety of approaches to antagonise NGF, including NGF 'capture', blocking the binding of NGF to trkA and inhibiting trkA signalling. NGF antagonism is expected to be a highly effective therapeutic approach in many pain states, and to be free of the adverse effects of traditional analgesic drugs.
Similar articles
- Antagonism of nerve growth factor-TrkA signaling and the relief of pain.
Mantyh PW, Koltzenburg M, Mendell LM, Tive L, Shelton DL. Mantyh PW, et al. Anesthesiology. 2011 Jul;115(1):189-204. doi: 10.1097/ALN.0b013e31821b1ac5. Anesthesiology. 2011. PMID: 21602663 Free PMC article. - Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor.
Eibl JK, Strasser BC, Ross GM. Eibl JK, et al. Neurochem Int. 2012 Dec;61(8):1266-75. doi: 10.1016/j.neuint.2012.10.008. Epub 2012 Oct 26. Neurochem Int. 2012. PMID: 23103525 Review. - Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat.
Owolabi JB, Rizkalla G, Tehim A, Ross GM, Riopelle RJ, Kamboj R, Ossipov M, Bian D, Wegert S, Porreca F, Lee DK. Owolabi JB, et al. J Pharmacol Exp Ther. 1999 Jun;289(3):1271-6. J Pharmacol Exp Ther. 1999. PMID: 10336516 - Analgesia via blockade of NGF/TrkA signaling does not influence fracture healing in mice.
Rapp AE, Kroner J, Baur S, Schmid F, Walmsley A, Mottl H, Ignatius A. Rapp AE, et al. J Orthop Res. 2015 Aug;33(8):1235-41. doi: 10.1002/jor.22892. Epub 2015 May 7. J Orthop Res. 2015. PMID: 25876530 - Targeting nerve growth factor in pain: what is the therapeutic potential?
Watson JJ, Allen SJ, Dawbarn D. Watson JJ, et al. BioDrugs. 2008;22(6):349-59. doi: 10.2165/0063030-200822060-00002. BioDrugs. 2008. PMID: 18998753 Review.
Cited by
- Anti-nerve growth factor in pain management: current evidence.
Chang DS, Hsu E, Hottinger DG, Cohen SP. Chang DS, et al. J Pain Res. 2016 Jun 8;9:373-83. doi: 10.2147/JPR.S89061. eCollection 2016. J Pain Res. 2016. PMID: 27354823 Free PMC article. Review. - Role of mast cells in male chronic pelvic pain.
Done JD, Rudick CN, Quick ML, Schaeffer AJ, Thumbikat P. Done JD, et al. J Urol. 2012 Apr;187(4):1473-82. doi: 10.1016/j.juro.2011.11.116. Epub 2012 Feb 17. J Urol. 2012. PMID: 22341813 Free PMC article. - Molecular simulation of the binding of nerve growth factor peptide mimics to the receptor tyrosine kinase A.
Berrera M, Cattaneo A, Carloni P. Berrera M, et al. Biophys J. 2006 Sep 15;91(6):2063-71. doi: 10.1529/biophysj.106.083519. Epub 2006 Jun 23. Biophys J. 2006. PMID: 16798810 Free PMC article. - Nerve growth factor-regulated emergence of functional delta-opioid receptors.
Bie B, Zhang Z, Cai YQ, Zhu W, Zhang Y, Dai J, Lowenstein CJ, Weinman EJ, Pan ZZ. Bie B, et al. J Neurosci. 2010 Apr 21;30(16):5617-28. doi: 10.1523/JNEUROSCI.5296-09.2010. J Neurosci. 2010. PMID: 20410114 Free PMC article. - Lactobacillus plantarum PS128 Ameliorated Visceral Hypersensitivity in Rats Through the Gut-Brain Axis.
Liu YW, Wang YP, Yen HF, Liu PY, Tzeng WJ, Tsai CF, Lin HC, Lee FY, Jeng OJ, Lu CL, Tsai YC. Liu YW, et al. Probiotics Antimicrob Proteins. 2020 Sep;12(3):980-993. doi: 10.1007/s12602-019-09595-w. Probiotics Antimicrob Proteins. 2020. PMID: 31691208
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical